Physician profile
Jonathan Chapekis
NPI 1104280007
$16,897.97
in general payments reported to CMS, 2019-2025
21 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $927 · 2023: $138 · 2024: $1,601 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $13K · Food and Beverage: $2,449 · Travel and Lodging: $533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $12,864.00 |
| Food and Beverage | $2,449.19 |
| Travel and Lodging | $533.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| International Rehabilitative Sciences, INC | $12,878.37 | 2024-2025 | Rs-Lbg, Rs-Sg, Rs-Fbg, Rs-4i Plus With Intersperse, Rs 4i Plus Sequential Stimulator |
| Nevro Corp. | $744.57 | 2022-2024 | Senza, Vyrsa V1 |
| Boston Scientific Corporation | $711.15 | 2024-2025 | Superion Indirect Decompression System, Intracept, General - Pain Management |
| Medtronic, INC. | $701.39 | 2022-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Inceptiv |
| Mml US, INC. | $252.39 | 2024-2025 | Reactiv8 |
| Spinal Simplicity, LLC | $222.33 | 2022-2025 | Ha Minuteman G3-R |
| Globus Medical, INC. | $216.52 | 2025 | Senza, Vyrsa V1 |
| Painteq LLC | $208.46 | 2022 | |
| Vertos Medical, INC. | $185.72 | 2022-2024 | Mild Device Kit |
| Allergan, INC. | $125.00 | 2021 | |
| Relievant Medsystems, INC. | $112.73 | 2022 | |
| Stryker Corporation | $99.82 | 2022 | |
| Forte Bio-Pharma LLC | $84.13 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Saluda Medical Americas, INC. | $82.54 | 2024 | Evoke |
| Trice Medical, INC. | $79.87 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $55.36 | 2025 | Qutenza |
| Scilex Pharmaceuticals INC. | $53.66 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $25.18 | 2025 | |
| Nalu Medical, INC. | $23.38 | 2025 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $20.53 | 2025 | Belbuca |
| Protega Pharmaceutials INC | $14.87 | 2025 | Roxybond |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Chapekis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.